Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-21
1994-03-08
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546123, C07D21516, A61K 3147
Patent
active
052927695
ABSTRACT:
Substituted mandelic acid derivatives can be prepared by reaction of glyoxylic esters with Grignard compounds. The substituted mandelic acid derivatives are suitable as active compounds in medicaments, in particular for medicaments which inhibit leukotriene synthesis.
REFERENCES:
patent: 4952695 (1990-08-01), Groche et al.
Jerry March, Advanced Organic Chemistry, pp. 837-840, (1977).
Houbey-Weyl, Methoden der organischen Chemie, (1973), pp. 289-302.
Uhlmann XII, pp. 367-375, (1976).
R. I. Trust, Organic Synthesis, 1973, pp. 116-122.
O. Grummitt, Org. Synth. Coll., vol. IV, 1963, pp. 771-775.
H. Adkins, Org. Synth. Coll., vol. II, 1943, pp. 606-608.
Gunter E. Jeromin, Chem. Ber., 1987, pp. 649-650.
Pierre Borgeat, Proc. Natl. Acad. Sci USA, May 1979, pp. 2148-2152.
Fruchtmann Romanis
Hatzelmann Armin
Kohlsdorfer Christian
Matzke Michael
Mohrs Klaus-Helmut
Bayer Aktiengesellschaft
Springer David B.
LandOfFree
Substituted mandelic acid derivatives and their use in medicamen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted mandelic acid derivatives and their use in medicamen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted mandelic acid derivatives and their use in medicamen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-153781